Go Pro

Carmignac Gestion Takes $6.58 Million Position in Astera Labs, Inc. $ALAB

Astera Labs logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Carmignac Gestion purchased 60,000 Astera Labs shares worth approximately $6.58 million, while other institutional investors also increased their positions; institutions now own 60.47% of the stock.
  • Astera Labs reported quarterly earnings of $0.61 per share, beating estimates of $0.54, while revenue rose 93.5% year over year to $308.36 million. The company issued second-quarter 2026 EPS guidance of $0.68–$0.70.
  • Insiders sold 1.68 million shares worth roughly $444.9 million over the past 90 days, although analyst sentiment remains a Moderate Buy, with 13 Buy ratings and 10 Holds.
  • MarketBeat previews top five stocks to own in September.

Carmignac Gestion purchased a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 60,000 shares of the company's stock, valued at approximately $6,576,000.

Several other large investors have also recently added to or reduced their stakes in the company. Royal Bank of Canada raised its holdings in shares of Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company's stock worth $9,097,000 after purchasing an additional 95,409 shares during the period. AQR Capital Management LLC boosted its holdings in shares of Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company's stock valued at $680,000 after buying an additional 7,756 shares during the period. Empowered Funds LLC grew its position in shares of Astera Labs by 917.3% during the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company's stock valued at $277,000 after buying an additional 4,183 shares during the last quarter. First Trust Advisors LP grew its position in shares of Astera Labs by 102.0% during the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company's stock valued at $10,196,000 after buying an additional 56,952 shares during the last quarter. Finally, Brown Advisory Inc. raised its stake in Astera Labs by 54.9% during the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company's stock worth $505,000 after acquiring an additional 1,977 shares during the period. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Price Performance

ALAB stock opened at $311.23 on Monday. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48. The firm's 50-day simple moving average is $359.97 and its 200 day simple moving average is $230.19. The stock has a market cap of $53.35 billion, a PE ratio of 210.29, a price-to-earnings-growth ratio of 3.61 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. Astera Labs's quarterly revenue was up 93.5% compared to the same quarter last year. During the same period last year, the firm posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts forecast that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

Insider Buying and Selling

In other news, COO Sanjay Gajendra sold 400,000 shares of the business's stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the transaction, the chief operating officer directly owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 686 shares of the stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total value of $270,997.44. Following the completion of the transaction, the director directly owned 5,550 shares of the company's stock, valued at $2,192,472. This trade represents a 11.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,676,845 shares of company stock valued at $444,928,806 in the last ninety days. Insiders own 10.40% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. Roth Capital reissued a "buy" rating and issued a $275.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. Susquehanna upped their target price on Astera Labs from $230.00 to $275.00 and gave the company a "neutral" rating in a report on Friday. Stifel Nicolaus increased their price target on Astera Labs from $260.00 to $460.00 and gave the stock a "buy" rating in a research report on Wednesday, June 24th. TD Cowen increased their price target on Astera Labs from $225.00 to $425.00 and gave the stock a "hold" rating in a research report on Monday, July 13th. Finally, Needham & Company LLC raised their price target on Astera Labs from $220.00 to $260.00 and gave the stock a "buy" rating in a report on Wednesday, May 6th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $284.25.

Read Our Latest Analysis on ALAB

Astera Labs Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Recommended Stories

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines